The semaglutide plateau hit hard and will not budge
Differences in cancer outcome definitions across trials were addressed by grouping clinically equivalent endpoints (e.g., hepatocellular carcinoma and primary liver cancer) and accounting for heterogeneity through random-effects modeling, sensitivity analyses, and GRADE downgrading for indirectness where appropriate
A major signal of this trend moving into Europe came in June 2025, when Hims & Hers announced its acquisition of Zava, a European telehealth platform with operations in the UK, Germany, France, and Ireland
Naturally, as interest in this powerful antioxidant grows, so do questions about potential side effects
If you are at week three and your trough is roughly 75% of what the plotter predicts for your steady-state trough, you know the medication is on track but not yet at full effect